RAPT Therapeutics, Inc. (RAPT) Total Assets by Year
RAPT Therapeutics, Inc. closed fiscal year 2024 with $240.3M in total assets, $50.4M in total liabilities and $189.9M in shareholder equity. This represents an increase of 38.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters RAPT Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RAPT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $240.3M+38.7% | $173.3M-34.9% | $266.2M+34.0% | $198.6M+67.0% | $119.0M+40.6% | $84.6M+21.5% | $69.6M |
| Total Liabilities | $50.4M+91.8% | $26.3M+25.0% | $21.0M+71.7% | $12.3M-17.1% | $14.8M+28.8% | $11.5M-93.1% | $166.7M |
| Total Equity | $189.9M+29.2% | $147.0M-40.0% | $245.2M+31.5% | $186.4M+78.9% | $104.2M+42.5% | $73.1M+175.3% | -$97.1M |
RAPT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $165.7M+52.8% | $178.4M+40.3% | $187.6M+20.4% | $240.3M+38.7% | $108.5M-45.7% | $127.2M-42.4% | $155.8M-37.3% | $173.3M-34.9% | $199.7M-4.7% | $220.8M-0.6% | $248.3M+32.4% | $266.2M+34.0% |
| Total Liabilities | $13.8M+6.2% | $14.0M-22.0% | $10.2M-59.2% | $50.4M+91.8% | $13.0M-51.9% | $18.0M-14.8% | $25.0M-10.3% | $26.3M+25.0% | $26.9M+33.4% | $21.1M+6.1% | $27.9M+41.3% | $21.0M+71.7% |
| Total Equity | $152.0M+59.1% | $164.4M+50.5% | $177.4M+35.6% | $189.9M+29.2% | $95.5M-44.7% | $109.2M-45.3% | $130.8M-40.7% | $147.0M-40.0% | $172.8M-8.7% | $199.7M-1.2% | $220.5M+31.4% | $245.2M+31.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More RAPT Therapeutics, Inc. financials
Frequently Asked Questions
What was RAPT Therapeutics, Inc.'s total assets in fiscal year 2024?
RAPT Therapeutics, Inc. closed fiscal year 2024 with $240.3M in total assets, $50.4M in total liabilities and $189.9M in shareholder equity.
How fast is RAPT Therapeutics, Inc.'s total assets growing?
RAPT Therapeutics, Inc. (RAPT) total assets rose by 38.7% year over year, from $173.3M to $240.3M in fiscal year 2024.
How has RAPT Therapeutics, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, RAPT Therapeutics, Inc. (RAPT) total assets went from $69.6M in fiscal year 2018 to $240.3M in fiscal year 2024.
What was RAPT Therapeutics, Inc.'s total assets in the most recent quarter?
RAPT Therapeutics, Inc. (RAPT) reported $165.7M in total assets in Q3 2025. This represents an increase of 52.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what RAPT Therapeutics, Inc. (RAPT) reported on that line in every period on record.